Literature DB >> 11819655

Lactosamination of liposomes and hepatotropic targeting research.

Yong-Peng Chen, Lian Zhang, Qiao-Sheng Lu, Xiao-Rong Feng, Kang-Xian Luo.   

Abstract

Year:  2000        PMID： 11819655      PMCID： PMC4723565          DOI： 10.3748/wjg.v6.i4.593

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  15 in total

1.  Proteins containing reductively aminated disaccharides. Synthesis and chemical characterization.

Authors:  B A Schwartz; G R Gray
Journal:  Arch Biochem Biophys       Date:  1977-06       Impact factor: 4.013

2.  An in vitro system for screening anti-hepatitis B virus drugs.

Authors:  K Ueda; T Tsurimoto; T Nagahata; O Chisaka; K Matsubara
Journal:  Virology       Date:  1989-03       Impact factor: 3.616

3.  Specific incorporation of asialofetuin-labeled liposomes into hepatocytes through the action of galactose-binding protein.

Authors:  T Hara; Y Aramaki; S Tsuchiya; K Hosoi; A Okada
Journal:  Biopharm Drug Dispos       Date:  1987 Jul-Aug       Impact factor: 1.627

4.  Interactions of immunoliposomes with target cells.

Authors:  A Huang; S J Kennel; L Huang
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

5.  A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay.

Authors:  R J Duncan; P D Weston; R Wrigglesworth
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Authors:  M A Sells; M L Chen; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

7.  Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly-L-lysine. Synthesis of the carrier and pharmacological properties of the conjugate.

Authors:  L Fiume; G Di Stefano; C Busi; A Mattioli; G Battista Gervasi; M Bertini; C Bartoli; R Catalani; G Caccia; C Farina; A Fissi; O Pieroni; R Giuseppetti; E D'Ugo; R Bruni; M Rapicetta
Journal:  J Hepatol       Date:  1997-02       Impact factor: 25.083

8.  Study on the anticarcinogenic effect and acute toxicity of liver-targeting mitoxantrone nanoparticles.

Authors:  Zhi-Rong Zhang; Qin He; Gong-Tie Liao; Shao-Huai Bai
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

9.  Coupling of the antiviral drug ara-AMP to lactosaminated albumin leads to specific uptake in rat and human hepatocytes.

Authors:  R W Jansen; J K Kruijt; T J van Berkel; D K Meijer
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

10.  Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA.

Authors:  Y Hayashi; K Koike
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103
View more
  2 in total

1.  Expression and bioactivity identification of soluble MG7 scFv.

Authors:  Zhao-Cai Yu; Jie Ding; Bo-Rong Pan; Dai-Ming Fan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Distribution and anti-HBV effects of antisense oligodeoxynucleotides conjugated to galactosylated poly-L-lysine.

Authors:  Su-Jun Zheng; Sen Zhong; Jian-Jun Zhang; Feng Chen; Hong Ren; Cun-Liang Deng
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.